EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence in Routine IVF Practice

Grzegorz Mrugacz, Aleksandra Mospinek iD, Małgorzata Jagielska, Dariusz Miszczak, Anna Matosek, Magdalena Ducher-Hanaka, Paweł Gustaw, Klaudia Januszewska, Aleksandra Grzegorczyk, Svetlana Pekar

Biology · 26.12.2025 · 15 (1) · 42

DOI: 10.3390/biology15010042 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 26.12.2025. Verfasst von Grzegorz Mrugacz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine Bocian, Białystok Branch, 26 Akademicka St., 15-267 Białystok, Poland. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Artificial Intelligence (AI) has emerged as a transformative tool in in vitro fertilization (IVF) as it has done in other sectors. In IVF, AI offers advancements in embryo selection, treatment personalization, and outcome prediction. It does so by leveraging deep learning and computer vision, as well as AI-driven platforms such as ERICA, iDAScore, and IVY where the goal is to address the limitations of traditional embryo assessment. Key amongst them are the issues of subjectivity, labor intensity, and limited predictive power. Despite rapid technological progress, the integration of AI into routine IVF practice faces key challenges. These are issues related to clinical validation, ethical dilemmas, and workflow adaptation. Rationale/Objectives: This review synthesizes current evidence to evaluate the role of AI in IVF, focusing on six critical dimensions: (1) the evolution of AI from traditional embryology to algorithmic assessment, (2) clinical validation and regulatory considerations, (3) limitations and ethical challenges, (4) pathways for clinical integration, (5) real-world applications and outcomes, and (6) future directions and policy recommendations. The objective is to provide a comprehensive roadmap for the responsible adoption of AI in reproductive medicine. Outcomes: AI demonstrates significant potential to improve the precision and efficiency of IVF. Studies report that AI models can achieve 10 to 25% higher accuracy in predicting embryo viability and implantation potential compared to traditional morphological assessment by embryologists. This enhanced predictive power supports more consistent embryo ranking, facilitates elective single-embryo transfer (eSET) strategies, and is associated with 30 to 50% reductions in embryologist workload per embryo cohort. Early adopters report promising trends. However, large-scale randomized controlled trials have yet to conclusively demonstrate a statistically significant increase in live birth rates per transfer compared to expert embryologist selection. The most immediate and evidenced value of AI lies in hybrid decision-making models. This is where it augments embryologists by providing data-driven, objective support, thereby standardizing workflows and reducing subjectivity. Wider Implications: The sustainable integration of AI into IVF banks on three key aspects: robust evidence generation, interdisciplinary collaboration, and global standardization. To foster these, policymakers ought to establish regulatory frameworks for transparency and bias mitigation. On their part, clinicians need training to interpret AI outputs critically. Ethically, safeguarding patient trust and equity is non-negotiable. Future innovations, mainly AI-enhanced genomics and real-time monitoring, could further personalize care. However, their success depends on addressing current limitations. By balancing innovation with ethical vigilance, AI holds the potential to revolutionize IVF while upholding the highest standards of patient care.

Schlagwörter

Stichwörter der Autor:innen

IVFartificial intelligenceclinical validationembryo selectionethicsinteroperability

Autor:innen und Institutionen

  • Center for Reproductive Medicine Bocian, Białystok Branch, 26 Akademicka St., 15-267 Białystok, Poland.
  • Center for Reproductive Medicine Bocian, Łódź Branch, 157a Piotrkowska St., 90-440 Łódź, Poland.
  • Center for Reproductive Medicine Bocian, Warszawa Branch, 2A Stawki St., 00-193 Warszawa, Poland.

ORCID-Profile: Aleksandra Mospinek

Zitieren

APA

Mrugacz, G., Mospinek, A., Jagielska, M., Miszczak, D., Matosek, A., Ducher-Hanaka, M., Gustaw, P., Januszewska, K., Grzegorczyk, A., & Pekar, S. (2025). Artificial Intelligence in Routine IVF Practice. Biology, 15(1), 42. https://doi.org/10.3390/biology15010042

Vancouver

Mrugacz G, Mospinek A, Jagielska M, Miszczak D, Matosek A, Ducher-Hanaka M, et al. Artificial Intelligence in Routine IVF Practice. Biology. 2025;15(1):42. doi:10.3390/biology15010042

BibTeX
@article{Mrugacz2025,
  author = {Mrugacz, Grzegorz and Mospinek, Aleksandra and Jagielska, Małgorzata and Miszczak, Dariusz and Matosek, Anna and Ducher-Hanaka, Magdalena and Gustaw, Paweł and Januszewska, Klaudia and Grzegorczyk, Aleksandra and Pekar, Svetlana},
  title = {Artificial Intelligence in Routine IVF Practice},
  journal = {Biology},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {42},
  doi = {10.3390/biology15010042}
}
Kostenlos starten →